Report #2898105

Received May 28, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: NM
Recovered: Unknown
Vaccinated: May 21, 2026
Onset: May 21, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RV5	ROTAVIRUS (ROTATEQ)	MERCK & CO. INC.	1	2155634	OT

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

Medical assistant confirmed that there were no symptomatic events reported by the patient's parents.; a patient (ages 20 weeks and 6 days) was given her first dose of ROTATEQ outside of the recommended 6 to 12 week starting dose indication; This spontaneous report was received from a medical assistant referring to a 20-weeks-old female patient. The patient's pertinent medical history, known drug reactions and allergies, and concomitant therapies were not reported. On 21-MAY-2026, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 2 mL, orally as prophylaxis (lot #2155634 has been verified to be valid, expiration date: 10-DEC-2026); outside of the recommended 6 to 12 week starting dose indication (Inappropriate schedule of product administration). Medical assistant confirmed that there were no symptomatic events reported by the patient's parents (No adverse event).